Drug Insights

Unveiling Omeprazole: How to Search for it on Synapse

31 January 2024
2 min read

Omeprazole is a proton pump inhibitor (PPI) commonly used to treat gastrointestinal disorders including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. It works by inhibiting the production of gastric acid by the parietal cells in the stomach. Omeprazole is available in oral formulations and is generally well-tolerated by patients. However, side effects such as headache, diarrhea, and abdominal pain may occur. Ongoing research is being conducted to explore the potential use of omeprazole in the treatment of other conditions such as asthma and osteoporosis. Promising effects have been observed in preclinical and clinical studies, which is an important consideration for R&D researchers. Click on the image below to begin the exploration journey of Omeprazole through the Synapse database!

图形用户界面, 应用程序

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

8-Year Study Reveals Superior Survival with Opdivo-Yervoy vs Sunitinib for Untreated Advanced Kidney Cancer
Latest Hotspot
3 min read
8-Year Study Reveals Superior Survival with Opdivo-Yervoy vs Sunitinib for Untreated Advanced Kidney Cancer
31 January 2024
Long-term results show Opdivo combined with Yervoy outlasts Sunitinib in survival outcomes for advanced or metastatic kidney cancer patients who haven't received prior treatment over an 8-year period.
Read →
Expert Tips for Searching Lisinopril on Synapse
Drug Insights
2 min read
Expert Tips for Searching Lisinopril on Synapse
31 January 2024
Lisinopril is an ACE inhibitor often prescribed for hypertension, heart failure, and other heart conditions.
Read →
FDA Approves Vanda Pharmaceuticals' VCA-894A Therapy for Charcot-Marie-Tooth Disease 2S
Latest Hotspot
3 min read
FDA Approves Vanda Pharmaceuticals' VCA-894A Therapy for Charcot-Marie-Tooth Disease 2S
31 January 2024
Vanda Pharmaceuticals Granted Green Light by FDA to Advance with Experimental Antisense Oligonucleotide Therapy, VCA-894A, for Managing Charcot-Marie-Tooth Disease, Subtype 2S.
Read →
Navigating Health Information: How to Use Synapse to Search for Hydroxyzine
Drug Insights
2 min read
Navigating Health Information: How to Use Synapse to Search for Hydroxyzine
31 January 2024
Hydroxyzine is a first-generation antihistamine that is commonly used for the treatment of various allergic conditions such as hives and itching.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.